- Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
-
Suzuki H, Shimose S, Iwamoto H, Niizeki T, Kawaguchi T
- KMID: 2554431
- Clin Mol Hepatol.
- 2024 Apr;30(2):263-265.
- doi: 10.3350/cmh.2023.0557
-
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
-
Iwamoto H, Shimose S, Niizeki T, Koga H, Torimura T, The Kurume Liver Cancer Study Group of Japan
- KMID: 2531380
- Clin Mol Hepatol.
- 2022 Jul;28(3):575-579.
- doi: 10.3350/cmh.2022.0047
-
- CITED
-
- Close
- SHARE
-
- Close
- Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
-
Shimose S, Koya S, Kawaguchi T, Hirota K, Yoshio S, Niizeki T, Matsuse H, Torimura T
- KMID: 2520844
- Clin Mol Hepatol.
- 2021 Oct;27(4):616-619.
- doi: 10.3350/cmh.2021.0258
-
- CITED
-
- Close
- SHARE
-
- Close
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
-
Koga H, Iwamoto H, Suzuki H, Shimose S, Nakano M, Kawaguchi T
- KMID: 2541403
- Clin Mol Hepatol.
- 2023 Apr;29(2):242-251.
- doi: 10.3350/cmh.2023.0102
Striking advances in systemic therapy for unresectable advanced hepatocellular carcinoma (HCC) have improved the average prognosis of patients with HCC. As a result, the guidelines for the treatment of HCC... -
- CITED
-
- Close
- SHARE
-
- Close
- Physical Signs and Clinical Features of Cervical Myelopathy in Elderly Patients, Especially 80 Years or Older: Comparison of 100 Consecutive Operative Cases across Three Age Groups
-
Hamasaki T, Nakamae T, Kamei N, Fujiwara Y, Rhee JM, Tanaka N, Fujimoto Y, Adachi N, Shimose S
- KMID: 2547588
- Asian Spine J.
- 2023 Oct;17(5):916-921.
- doi: 10.31616/asj.2022.0463
Study Design: Retrospective cohort study. Purpose: The present study aimed to examine the characteristics of physical signs in elderly patients with cervical myelopathy (CM) and to compare the findings in three... -
- CITED
-
- Close
- SHARE
-
- Close
